Pharmaceutical Preparations 27 companies · $467.06B combined revenue
SIC 2834 · official SEC filings
| # | Ticker | Company | Mkt Cap* | Revenue | Net Income | Sector |
|---|---|---|---|---|---|---|
| 1 | JNJ | Johnson & Johnson | $367.00B | $94.19B | $26.80B | Pharmaceutical Preparations |
| 2 | LLY | Eli Lilly & Co | $807.89B | $65.18B | $20.64B | Pharmaceutical Preparations |
| 3 | MRK | Merck & Co., Inc. | $198.05B | $65.01B | $18.26B | Pharmaceutical Preparations |
| #4 | PFE | Pfizer Inc | $138.00B | $62.58B | $7.81B | Pharmaceutical Preparations |
| #5 | ABBV | Abbvie Inc. | $325.06B | $61.16B | $4.23B | Pharmaceutical Preparations |
| #6 | BMY | Bristol Myers Squibb Co | $94.19B | $48.19B | $7.05B | Pharmaceutical Preparations |
| #7 | REGN | Regeneron Pharmaceuticals, Inc. | $54.80B | $14.34B | $4.50B | Pharmaceutical Preparations |
| #8 | VTRS | Viatris Inc | $10.38B | $14.30B | $-3.51B | Pharmaceutical Preparations |
| #9 | VRTX | Vertex Pharmaceuticals Inc / Ma | $113.40B | $12.00B | $3.95B | Pharmaceutical Preparations |
| #10 | BHC | Bausch Health Companies Inc. | $2.00B | $10.27B | $120.00M | Pharmaceutical Preparations |
| #11 | ZTS | Zoetis Inc. | $69.23B | $9.47B | $2.67B | Pharmaceutical Preparations |
| #12 | ALNY | Alnylam Pharmaceuticals, Inc. | $42.63B | $3.71B | $313.75M | Pharmaceutical Preparations |
| #13 | PTCT | Ptc Therapeutics, Inc. | $3.35M | $1.73B | $682.64M | Pharmaceutical Preparations |
| #14 | INDV | Indivior Pharmaceuticals, Inc. | $1.83B | $1.24B | $210.00M | Pharmaceutical Preparations |
| #15 | SUPN | Supernus Pharmaceuticals, Inc. | $1.69B | $718.95M | $-38.55M | Pharmaceutical Preparations |
| #16 | KNSA | Kiniksa Pharmaceuticals International, Plc | $1.11B | $677.56M | $59.01M | Pharmaceutical Preparations |
| #17 | INSM | Insmed Inc | $21.10B | $606.42M | $-1.28B | Pharmaceutical Preparations |
| #18 | BBIO | Bridgebio Pharma, Inc. | $7.30B | $502.08M | $-732.94M | Pharmaceutical Preparations |
| #19 | AUPH | Aurinia Pharmaceuticals Inc. | $1.00B | $283.06M | $287.20M | Pharmaceutical Preparations |
| #20 | LGND | Ligand Pharmaceuticals Inc | $1.60B | $268.09M | $124.45M | Pharmaceutical Preparations |
| #21 | VNDA | Vanda Pharmaceuticals Inc. | $268.70M | $216.10M | $-220.47M | Pharmaceutical Preparations |
| #22 | AMRN | Amarin Corp Plc\Uk | $334.70M | $213.65M | $-38.80M | Pharmaceutical Preparations |
| #23 | NRIX | Nurix Therapeutics, Inc. | $807.50M | $83.98M | $-264.46M | Pharmaceutical Preparations |
| #24 | BCYC | Bicycle Therapeutics Plc | $266.67M | $72.59M | $-218.96M | Pharmaceutical Preparations |
| #25 | WVE | Wave Life Sciences, Inc. | $851.01M | $42.73M | $-204.38M | Pharmaceutical Preparations |
| #26 | VKTX | Viking Therapeutics, Inc. | $2.98B | – | $-359.64M | Pharmaceutical Preparations |
| #27 | ABT | Abbott Laboratories | $232.17B | – | $7.07B | Pharmaceutical Preparations |